CBIO
Financials
- Market Capitalization 659.3 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2021 |  GENB Generate Biomedicines, Inc. - Common Stock | 15.33 USD | -2.79% | -8.53% | +16.93% | +2.20% | 1.97 B USD | ||
| 2181 |  MAZE Maze Therapeutics, Inc. - Common Stock | 27.44 USD | -4.06% | -6.25% | -0.11% | -39.06% | 1.52 B USD | ||
| 2815 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD | ||
| 2986 |  QTTB Q32 Bio Inc. - Common Stock | 15.03 USD | -6.93% | -9.24% | +2.87% | +810.91% | 447.44 M USD |
Frequently asked questions about Crescent Biopharma, Inc. Common Stock
What is the Crescent Biopharma, Inc. Common Stock stock price today?
The current price of Crescent Biopharma, Inc. Common Stock (CBIO) is 17.75. Over the past 24 hours, the stock has changed by -0.06%. Follow the CBIO chart for real-time price dynamics.
What is the stock ticker of Crescent Biopharma, Inc. Common Stock?
Crescent Biopharma, Inc. Common Stock trades under the ticker CBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Crescent Biopharma, Inc. Common Stock stock going up?
CBIO has changed by +3.50% over the last week, +21.08% over the last month, and +22.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Crescent Biopharma, Inc. Common Stock?
Crescent Biopharma, Inc. Common Stock currently has a market capitalization of 659.3 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What was Crescent Biopharma, Inc. Common Stock revenue for the last quarter?
Crescent Biopharma, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Crescent Biopharma, Inc. Common Stock net income for the last quarter?
Crescent Biopharma, Inc. Common Stock reported net income of -24.84 M for the last quarter. The previous quarter showed -23.28 M, which means net income changed by -6.67%.
How many employees does Crescent Biopharma, Inc. Common Stock have?
As of the latest available data, Crescent Biopharma, Inc. Common Stock has 44 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Crescent Biopharma, Inc. Common Stock stock?
You can buy Crescent Biopharma, Inc. Common Stock (CBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Crescent Biopharma, Inc. Common Stock stock?
Investing in Crescent Biopharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CBIO chart and related analysis on metatrader.com as part of your research.